Sandbox:iqra: Difference between revisions
Jump to navigation
Jump to search
| Line 93: | Line 93: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Thrombosis of portal, hepatic, or splenic veins | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Thrombosis]] of [[portal]], [[Liver|hepatic]], or [[Splenic vein|splenic veins]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 121: | Line 121: | ||
|- | |- | ||
! rowspan="8" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Malignancy | ! rowspan="8" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Malignancy | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Lymphoma | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Lymphoma]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 148: | Line 148: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" | | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Leukemia]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 175: | Line 175: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Polycythemia Vera | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Polycythemia vera|Polycythemia Vera]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 202: | Line 202: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Multiple myeloma | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Multiple myeloma]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 229: | Line 229: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Essential thrombocythemia | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Essential thrombocytosis|Essential thrombocythemia]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 256: | Line 256: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Primary myelofibrosis | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Myelofibrosis|Primary myelofibrosis]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 283: | Line 283: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Primary splenic tumors | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Splenic tumor|Primary splenic tumors]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 310: | Line 310: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Metastatic solid tumors | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Metastasis|Metastatic solid tumors]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 365: | Line 365: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings | ||
|- | |- | ||
! rowspan=" | ! rowspan="12" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Infection | ||
! align="center" style="background:#DCDCDC;" |Viral | ! rowspan="3" align="center" style="background:#DCDCDC;" |[[Virus|Viral]] | ||
! align="center" style="background:#DCDCDC;" |Hepatitis | ! align="center" style="background:#DCDCDC;" |[[Hepatitis]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 394: | Line 394: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Bacterial | ![[Mononucleosis|Infectious mononucleosis]] | ||
! align="center" style="background:#DCDCDC;" |Salmonella | ! | ||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
|- | |||
![[Cytomegalovirus]] | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
|- | |||
! rowspan="3" align="center" style="background:#DCDCDC;" |[[Bacteria|Bacterial]] | |||
! align="center" style="background:#DCDCDC;" |[[Salmonella]] | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 422: | Line 476: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! rowspan=" | ![[Brucella]] | ||
! align="center" style="background:#DCDCDC;" |Malaria | ! | ||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
|- | |||
![[Tuberculosis]] | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
|- | |||
! rowspan="4" align="center" style="background:#DCDCDC;" |[[Parasitism|Parasitic]] | |||
! align="center" style="background:#DCDCDC;" |[[Malaria]] | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 450: | Line 558: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Kala-azar | ![[Schistosomiasis]] | ||
| align="center" style="background:#F5F5F5;" | | ! | ||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
|- | |||
![[Toxoplasmosis]] | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
|- | |||
! align="center" style="background:#DCDCDC;" |[[Visceral leishmaniasis|Kala-azar]] | |||
| align="center" style="background:#F5F5F5;" |[[Visceral leishmaniasis]] | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 477: | Line 639: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Infective endocarditis | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Endocarditis|Infective endocarditis]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 504: | Line 666: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Fungal | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Fungus|Fungal]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 532: | Line 694: | ||
|- | |- | ||
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Inflammation | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Inflammation | ||
! colspan="2" align="center" style="background:#DCDCDC;" | | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Sarcoidosis]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 559: | Line 721: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Serum sickness | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Serum sickness]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 586: | Line 748: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Systemic lupus erythematosus | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Systemic lupus erythematosus]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 613: | Line 775: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Felty syndrome | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Felty's syndrome|Felty syndrome]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 669: | Line 831: | ||
|- | |- | ||
! rowspan="6" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Infiltrative | ! rowspan="6" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Infiltrative | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Gaucher disease | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Gaucher's disease|Gaucher disease]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 696: | Line 858: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Niemann-Pick disease | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Niemann-Pick disease]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 723: | Line 885: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Amyloidosis | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Amyloidosis]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 750: | Line 912: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Langerhans cell histiocytosis | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Langerhans cell histiocytosis]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 777: | Line 939: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Hemophagocytic lymphohistiocytosis | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Hemophagocytic lymphohistiocytosis]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 804: | Line 966: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Rosai-Dorfman disease | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Rosai Dorfman disease|Rosai-Dorfman disease]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 832: | Line 994: | ||
|- | |- | ||
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hematologic (hypersplenic) states | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hematologic (hypersplenic) states | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Hemolytic anemia | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Hemolytic anemia]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 859: | Line 1,021: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Sickle cell disease | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Sickle-cell disease|Sickle cell disease]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 886: | Line 1,048: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Granulocyte colony-stimulating factor | ! colspan="2" align="center" style="background:#DCDCDC;" |[[Granulocyte colony-stimulating factor]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Revision as of 22:46, 25 September 2018
Splenomegaly differential:
| Category | Disease | Etiology | Clinical manifestations | Para−clinical findings | Gold standard | Associated findings | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Demography | History | Symptoms | Signs | Lab Findings | Imaging | ||||||||||||||||||||||
| Fever | Fatigue | Weight loss | Abdominal pain | Bleeding | BP | JVP | Jaundice | Ascites | Other | CBC | PS | Iron | LFT | PT/PTT | BUN/Cr | UA | |||||||||||
| WBC | Hb | Plt | |||||||||||||||||||||||||
| Congestive | Cirrhosis | ||||||||||||||||||||||||||
| Heart failure | |||||||||||||||||||||||||||
| Thrombosis of portal, hepatic, or splenic veins | |||||||||||||||||||||||||||
| Malignancy | Lymphoma | ||||||||||||||||||||||||||
| Leukemia | |||||||||||||||||||||||||||
| Polycythemia Vera | |||||||||||||||||||||||||||
| Multiple myeloma | |||||||||||||||||||||||||||
| Essential thrombocythemia | |||||||||||||||||||||||||||
| Primary myelofibrosis | |||||||||||||||||||||||||||
| Primary splenic tumors | |||||||||||||||||||||||||||
| Metastatic solid tumors | |||||||||||||||||||||||||||
| Category | Disease | Etiology | Demography | History | Fever | Fatigue | Weight loss | Abdominal pain | Bleeding | BP | JVP | Jaundice | Ascites | Other | WBC | Hb | Plt | PS | Iron | LFT | PT/PTT | BUN/Cr | UA | Imaging | Gold standard | Associated findings | |
| Infection | Viral | Hepatitis | |||||||||||||||||||||||||
| Infectious mononucleosis | |||||||||||||||||||||||||||
| Cytomegalovirus | |||||||||||||||||||||||||||
| Bacterial | Salmonella | ||||||||||||||||||||||||||
| Brucella | |||||||||||||||||||||||||||
| Tuberculosis | |||||||||||||||||||||||||||
| Parasitic | Malaria | ||||||||||||||||||||||||||
| Schistosomiasis | |||||||||||||||||||||||||||
| Toxoplasmosis | |||||||||||||||||||||||||||
| Kala-azar | Visceral leishmaniasis | ||||||||||||||||||||||||||
| Infective endocarditis | |||||||||||||||||||||||||||
| Fungal | |||||||||||||||||||||||||||
| Inflammation | Sarcoidosis | ||||||||||||||||||||||||||
| Serum sickness | |||||||||||||||||||||||||||
| Systemic lupus erythematosus | |||||||||||||||||||||||||||
| Felty syndrome | |||||||||||||||||||||||||||
| Category | Disease | Etiology | Demography | History | Fever | Fatigue | Weight loss | Abdominal pain | Bleeding | BP | JVP | Jaundice | Ascites | Other | WBC | Hb | Plt | PS | Iron | LFT | PT/PTT | BUN/Cr | UA | Imaging | Gold standard | Associated findings | |
| Infiltrative | Gaucher disease | ||||||||||||||||||||||||||
| Niemann-Pick disease | |||||||||||||||||||||||||||
| Amyloidosis | |||||||||||||||||||||||||||
| Langerhans cell histiocytosis | |||||||||||||||||||||||||||
| Hemophagocytic lymphohistiocytosis | |||||||||||||||||||||||||||
| Rosai-Dorfman disease | |||||||||||||||||||||||||||
| Hematologic (hypersplenic) states | Hemolytic anemia | ||||||||||||||||||||||||||
| Sickle cell disease | |||||||||||||||||||||||||||
| Granulocyte colony-stimulating factor | |||||||||||||||||||||||||||
| Category | Disease | Etiology | Demography | History | Fever | Fatigue | Weight loss | Abdominal pain | Bleeding | BP | JVP | Jaundice | Ascites | Other | WBC | Hb | Plt | PS | Iron | LFT | PT/PTT | BUN/Cr | UA | Imaging | Gold standard | Associated findings | |